Strategic Partners A/S
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a OZYMF research report →
Companywww.strategic-partners.dk
Strategic Partners A/S does not have significant operations. Previously, it was engaged in biotech activities. The company was formerly known as Orphazyme A/S and changed its name to Strategic Partners A/S in October 2024.
- CEO
- Jakob Færch Bendtsen
- IPO
- 2019
- Employees
- 1
- HQ
- Copenhagen, DK
Price Chart
Valuation
- Market Cap
- $3.72M
- P/E
- -29.62
- P/S
- 81.63
- P/B
- 1.38
- EV/EBITDA
- -10.15
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 100.00%
- Op Margin
- -791.59%
- Net Margin
- -277.99%
- ROE
- -4.71%
- ROIC
- -13.30%
Growth & Income
- Revenue
- $309.00K · 0.00%
- Net Income
- $-859,000 · -288155.03%
- EPS
- $-21.00 · 0.00%
- Op Income
- $-2,446,000
- FCF YoY
- 0.00%
Performance & Tape
- 52W High
- $90.00
- 52W Low
- $0.09
- 50D MA
- $90.00
- 200D MA
- $90.00
- Beta
- 0.14
- Avg Volume
- 1.72K
Get TickerSpark's AI analysis on OZYMF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our OZYMF Coverage
We haven't published any research on OZYMF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate OZYMF Report →